https://thebostonexaminer.com/article/912600869-health-imperatives-announces-upcoming-leadership-changes The Boston Examiner en PressRelease 2026-05-13T20:39:12+00:00 Health Imperatives Announces Upcoming Leadership Changes https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856039-julia-kehoe-and-stephanie-brown-1920x800.png https://thebostonexaminer.com/article/912057328-efcg-and-msa-professional-services-launch-imeritus-pilot-to-transform-institutional-knowledge-into-a-capital-asset The Boston Examiner en PressRelease 2026-05-13T20:35:38+00:00 EFCG and MSA Professional Services Launch IMERITUS Pilot to Transform Institutional Knowledge into a Capital Asset https://thebostonexaminer.com/article/912559091-peloton-consulting-announces-strategic-investment-from-sunstone-partners-to-accelerate-ai-enabled-innovation-and-growth The Boston Examiner en PressRelease 2026-05-13T19:27:45+00:00 Peloton Consulting Announces Strategic Investment from Sunstone Partners to Accelerate AI Enabled Innovation and Growth https://thebostonexaminer.com/article/912578609-ballers-seaport-announces-grand-opening-weekend-celebration-featuring-fitness-classes-challenges-cold-plunges-more The Boston Examiner en PressRelease 2026-05-13T18:41:40+00:00 Ballers Seaport Announces Grand Opening Weekend Celebration Featuring Fitness Classes, Challenges, Cold Plunges & More https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833517-ballers-seaport-aerial-1206x898.jpeg https://thebostonexaminer.com/article/912029187-study-9-in-10-college-students-want-to-debate-but-66-stay-silent The Boston Examiner en PressRelease 2026-05-13T13:30:00+00:00 Study: 9 in 10 College Students Want to Debate — but 66% Stay Silent https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854788-banjo-discourse-divide-infogr-2400x1256.jpeg https://thebostonexaminer.com/article/912458959-beyond-the-click-onescreen-s-68-q1-surge-signals-a-new-era-of-high-confidence-marketing-in-the-real-world The Boston Examiner en PressRelease 2026-05-13T13:00:00+00:00 Beyond the Click: Onescreen's 68% Q1 Surge Signals a New Era of High-Confidence Marketing in the Real World https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855297-os-logo-2227x241.png https://thebostonexaminer.com/article/912295653-massachusetts-schools-can-now-use-state-grant-funding-for-bell-to-bell-phone-storage-solutions The Boston Examiner en PressRelease 2026-05-13T12:31:10+00:00 Massachusetts Schools Can Now Use State Grant Funding for Bell-to-Bell Phone Storage Solutions https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24630407-nukase-logo2-800x313.png https://thebostonexaminer.com/article/912315675-lydonia-sponsors-automation-anywhere-imagine-2026-conference-advancing-focus-on-ai-value The Boston Examiner en PressRelease 2026-05-13T12:00:00+00:00 Lydonia Sponsors Automation Anywhere Imagine 2026 Conference, Advancing Focus on AI Value https://thebostonexaminer.com/article/912275488-violet-therapeutics-raises-4-75m-seed-extension-to-advance-novel-therapeutic-for-synaptic-preservation-and-repair The Boston Examiner en PressRelease 2026-05-13T09:00:00+00:00 Violet Therapeutics Raises $4.75M Seed Extension to Advance Novel Therapeutic for Synaptic Preservation and Repair https://thebostonexaminer.com/article/912602850-precision-optics-reports-third-quarter-fiscal-year-2026-financial-results The Boston Examiner en PressRelease 2026-05-13T20:30:00+00:00 Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://thebostonexaminer.com/article/912603349-rapid-micro-biosystems-reports-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-05-13T20:25:58+00:00 Rapid Micro Biosystems Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://thebostonexaminer.com/article/912602856-acrivon-reports-first-quarter-2026-financial-results-and-highlights-progress-towards-key-2026-clinical-catalysts The Boston Examiner en PressRelease 2026-05-13T20:10:00+00:00 Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg https://thebostonexaminer.com/article/912603310-tango-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-highlights The Boston Examiner en PressRelease 2026-05-13T20:07:25+00:00 Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png https://thebostonexaminer.com/article/912602348-spero-therapeutics-announces-first-quarter-2026-operating-results-and-provides-business-update The Boston Examiner en PressRelease 2026-05-13T20:05:00+00:00 Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg https://thebostonexaminer.com/article/912602376-wave-life-sciences-to-present-at-2026-rbc-capital-markets-global-healthcare-conference The Boston Examiner en PressRelease 2026-05-13T20:05:00+00:00 Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://thebostonexaminer.com/article/912578647-the-sewerage-and-water-board-of-new-orleans-selects-cdm-smith-to-manage-1-billion-lead-line-replacement-program The Boston Examiner en PressRelease 2026-05-13T18:00:00+00:00 The Sewerage and Water Board of New Orleans selects CDM Smith to manage $1 billion lead line replacement program https://ml.globenewswire.com/media/YjNlODY1MTMtOTI0OS00NmQ2LTliZGUtNDQ0YzM2ZThjYTI2LTEyNDUwODEtMjAyNi0wNS0xMy1lbg==/tiny/CDM-Smith.png https://thebostonexaminer.com/article/912533857-ai-powered-plastics-recycling-gains-momentum-as-investment-surges-and-technology-delivers-measurable-roi The Boston Examiner en PressRelease 2026-05-13T14:09:12+00:00 AI-Powered Plastics Recycling Gains Momentum as Investment Surges and Technology Delivers Measurable ROI https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://thebostonexaminer.com/article/912533560-quickbase-expands-real-time-ai-capabilities-for-field-service-teams The Boston Examiner en PressRelease 2026-05-13T14:00:00+00:00 Quickbase Expands Real-Time AI Capabilities for Field Service Teams  https://ml.globenewswire.com/media/348bbc98-87d0-4dbd-8ee3-749e93775583/small/quickbase-logo-fullcolor-dune-png.png https://thebostonexaminer.com/article/912532771-ip-fabric-expands-netbox-integration-to-deliver-continuous-network-validation-for-enterprise-operations The Boston Examiner en PressRelease 2026-05-13T13:04:00+00:00 IP Fabric Expands NetBox Integration to Deliver Continuous Network Validation for Enterprise Operations https://ml.globenewswire.com/media/097f9a64-fb8d-41a9-bb00-70f61fc84bdd/medium/network-automation-ecosystem.png https://thebostonexaminer.com/article/912532870-wolf-company-p-c-continues-national-expansion-with-presence-in-florida-and-texas The Boston Examiner en PressRelease 2026-05-13T13:00:00+00:00 Wolf & Company, P.C. Continues National Expansion With Presence In Florida And Texas https://ml.globenewswire.com/media/YjFhYmE3ZDktN2ExNi00NDhmLTkxNTMtNTQ2MDFiNGU0MmY5LTUwMDE1ODI3NC0yMDI2LTA1LTEzLWVu/tiny/Wolf-Company-P-C-.png https://thebostonexaminer.com/article/912533182-vicarious-surgical-demonstrates-sustained-system-performance-and-complex-hernia-procedure-workflows-in-pre-clinical-setting The Boston Examiner en PressRelease 2026-05-13T13:00:00+00:00 Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting https://ml.globenewswire.com/media/MzM2MmFiNjItZDU1Yi00MTdiLTkyYTctNTk1ZmMxODcwNjYwLTEyMTM5OTQtMjAyNi0wNS0xMy1lbg==/tiny/Vicarious-Surgical.png https://thebostonexaminer.com/article/912532630-aware-announces-successful-independent-evaluation-of-intelligent-liveness-aligned-with-cen-ts-18099 The Boston Examiner en PressRelease 2026-05-13T12:30:00+00:00 Aware Announces Successful Independent Evaluation of Intelligent Liveness Aligned with CEN/TS 18099 https://ml.globenewswire.com/media/a04f465c-3b1c-4f2a-a547-3fcb543ddaa2/small/aware-logo-for-press-releases-jpg.jpg https://thebostonexaminer.com/article/912532659-bicara-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-13T12:30:00+00:00 Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://thebostonexaminer.com/article/912532759-rectify-pharmaceuticals-to-present-preclinical-data-on-new-dual-targeted-abcb4-bsep-positive-functional-modulator-at-easl-2026 The Boston Examiner en PressRelease 2026-05-13T12:30:00+00:00 Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026 https://ml.globenewswire.com/media/bdac6aa0-18b4-4330-98a1-e9673a671b69/small/rectify-logo-color-jpg.jpg https://thebostonexaminer.com/article/912532964-nha-s-2026-industry-outlook-highlights-growing-need-for-allied-health-professionals-and-the-rising-value-of-certification The Boston Examiner en PressRelease 2026-05-13T12:30:00+00:00 NHA’s 2026 Industry Outlook Highlights Growing Need for Allied Health Professionals and the Rising Value of Certification https://ml.globenewswire.com/media/MzAyYWQyYzEtZjgzYS00N2M0LWExZjMtNjI1MjRlNjJmN2YwLTEyMDA5MjYtMjAyNi0wNS0xMy1lbg==/tiny/Ascend-Learning-Inc-.png https://thebostonexaminer.com/article/912533320-vor-bio-reports-first-quarter-2026-financial-results-and-provides-corporate-update The Boston Examiner en PressRelease 2026-05-13T12:30:00+00:00 Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://thebostonexaminer.com/article/912509747-excelsoft-technologies-achieves-50-60-faster-software-delivery-with-ai-sprints-coaching The Boston Examiner en PressRelease 2026-05-13T12:11:00+00:00 Excelsoft Technologies Achieves 50%–60% Faster Software Delivery With AI Sprints Coaching https://ml.globenewswire.com/media/64e66cfb-6b7a-4497-a917-76945f51a76f/small/aisprintslogo300dpi-png.png https://thebostonexaminer.com/article/912508626-candel-therapeutics-to-present-at-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-13T12:05:00+00:00 Candel Therapeutics to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://thebostonexaminer.com/article/912508652-sionna-therapeutics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference The Boston Examiner en PressRelease 2026-05-13T12:00:00+00:00 Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://thebostonexaminer.com/article/912508664-acronis-introduces-cyber-frame-addressing-service-provider-demand-for-profitable-reliable-and-protected-iaas The Boston Examiner en PressRelease 2026-05-13T12:00:00+00:00 Acronis Introduces Cyber Frame, Addressing Service Provider Demand for Profitable, Reliable, and Protected IaaS https://ml.globenewswire.com/media/7dfe00a6-5f9c-4761-a63e-daa24c010a4a/medium/acronis-cyber-frame.png https://thebostonexaminer.com/article/912508718-cerence-ai-to-participate-in-td-cowen-54th-annual-technology-media-telecom-conference The Boston Examiner en PressRelease 2026-05-13T12:00:00+00:00 Cerence AI to Participate in TD Cowen 54th Annual Technology, Media & Telecom Conference https://ml.globenewswire.com/media/873690ee-866c-4dea-9808-10aecc02890f/small/cerence-ai-logo-full-color-h-1-png.png https://thebostonexaminer.com/article/912508895-dyne-therapeutics-to-participate-in-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-13T11:30:00+00:00 Dyne Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://thebostonexaminer.com/article/912508944-pyxis-oncology-to-participate-in-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-13T11:30:00+00:00 Pyxis Oncology to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://thebostonexaminer.com/article/912509177-hengrui-pharma-and-kailera-therapeutics-announce-clinical-data-presentations-at-the-american-diabetes-association-86th-scientific-sessions The Boston Examiner en PressRelease 2026-05-13T11:30:00+00:00 Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://thebostonexaminer.com/article/912509688-workable-launches-mcp-server-for-ai-powered-recruiting-and-hr-workflows The Boston Examiner en PressRelease 2026-05-13T11:21:14+00:00 Workable Launches MCP Server for AI-Powered Recruiting and HR Workflows https://ml.globenewswire.com/media/514c6a69-6edc-4085-9b6e-3fae732d70ba/medium/workable-launches-mcp-server.png https://thebostonexaminer.com/article/912508737-beam-therapeutics-to-present-at-2026-rbc-capital-markets-global-healthcare-conference The Boston Examiner en PressRelease 2026-05-13T11:00:00+00:00 Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://thebostonexaminer.com/article/912508742-atea-pharmaceuticals-to-present-three-abstracts-at-easl-2026-congress-highlighting-progress-across-viral-hepatitis-pipeline The Boston Examiner en PressRelease 2026-05-13T11:00:00+00:00 Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://thebostonexaminer.com/article/912508907-corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-13T11:00:00+00:00 Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://thebostonexaminer.com/article/912509297-upstream-bio-reports-first-quarter-2026-financial-results-and-recent-business-highlights The Boston Examiner en PressRelease 2026-05-13T11:00:00+00:00 Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://thebostonexaminer.com/article/912509105-zenas-biopharma-announces-first-subject-dosed-in-phase-1-clinical-trial-of-zb021-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor The Boston Examiner en PressRelease 2026-05-13T10:50:00+00:00 Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://thebostonexaminer.com/article/912483877-voyager-asgct-late-breaker-single-iv-dose-of-vy1706-well-tolerated-reduced-tau-in-3-month-glp-toxicology-data-clinical-trial-in-alzheimer-s-disease The Boston Examiner en PressRelease 2026-05-13T10:01:00+00:00 Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png https://thebostonexaminer.com/article/912483898-zenas-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-update The Boston Examiner en PressRelease 2026-05-13T10:00:00+00:00 Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://thebostonexaminer.com/article/912329227-best-mortgage-loan-officers-in-worcester-county-for-2026-and-why-ben-naranjo-leads-the-pack The Boston Examiner en PressRelease 2026-05-12T20:43:11+00:00 Best Mortgage Loan Officers in Worcester County for 2026 (And Why Ben Naranjo Leads the Pack) https://thebostonexaminer.com/article/912464757-fortis-life-sciences-vergibt-den-abnano-vhh-discovery-grant-2026-an-deliver-biosciences-im-bereich-der-gezielten-wirkstoffabgabe The Boston Examiner en PressRelease 2026-05-13T06:20:00+00:00 Fortis Life Sciences vergibt den AbNano® VHH Discovery Grant 2026 an Deliver Biosciences im Bereich der gezielten Wirkstoffabgabe https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://thebostonexaminer.com/article/912464760-fortis-life-sciences-attribue-la-subvention-la-d-couverte-abnano-vhh-discovery-2026-deliver-biosciences-pour-la-recherche-sur-l-administration The Boston Examiner en PressRelease 2026-05-13T06:20:00+00:00 Fortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicaments https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://thebostonexaminer.com/article/912235850-scroops-com-launches-ai-voice-rehearsal-platform-to-rebuild-social-skills The Boston Examiner en PressRelease 2026-05-12T16:00:00+00:00 Scroops.com Launches AI Voice Rehearsal Platform to Rebuild Social Skills https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854154-scroops-com-hp-14-202605121256-2400x1350.png https://thebostonexaminer.com/article/912265559-gsk-global-ciso-warns-the-quantum-threat-to-enterprise-security-is-already-here The Boston Examiner en PressRelease 2026-05-12T15:52:21+00:00 GSK Global CISO Warns: The Quantum Threat to Enterprise Security Is Already Here https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854350-michael-elmore-pr-1200x628.png https://thebostonexaminer.com/article/911332180-new-england-patriots-rb-treveyon-henderson-writes-foreword-for-gripped-part-6-the-dunkin-legacy The Boston Examiner en PressRelease 2026-05-12T14:30:00+00:00 New England Patriots RB TreVeyon Henderson Writes Foreword for 'Gripped Part 6: The Dunkin Legacy' https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851053-treveyon-henderson-3035x2023.jpeg https://thebostonexaminer.com/article/912032393-contracts-365-launches-governed-ai-negotiation-companion-for-microsoft-365-enterprises The Boston Examiner en PressRelease 2026-05-12T14:15:00+00:00 Contracts 365 Launches Governed AI Negotiation Companion for Microsoft 365 Enterprises https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23952032-contracts-365-black-logo-3860x540.jpeg https://thebostonexaminer.com/article/912227544-poseidon-s-forge-announces-sale-of-darkwake-auv-to-booz-allen-hamilton-to-accelerate-rapid-payload-integration The Boston Examiner en PressRelease 2026-05-12T14:00:00+00:00 Poseidon’s Forge Announces Sale of DarkWake AUV to Booz Allen Hamilton to Accelerate Rapid Payload Integration https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854107-darkwake-on-beach-1800x1200.png https://thebostonexaminer.com/article/912241698-dr-karen-may-newman-to-receive-asaio-pushpa-and-kewal-gupta-lifetime-achievement-award The Boston Examiner en PressRelease 2026-05-12T13:31:02+00:00 Dr. Karen May-Newman to Receive ASAIO Pushpa and Kewal Gupta Lifetime Achievement Award https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854190-asaio-2026-annual-conference-1050x300.jpeg https://thebostonexaminer.com/article/912240527-dr-gus-rosenberg-to-receive-asaio-kamal-and-narayan-bonde-lifetime-achievement-award-in-artificial-organs-development The Boston Examiner en PressRelease 2026-05-12T13:22:18+00:00 Dr. Gus Rosenberg to Receive ASAIO Kamal and Narayan Bonde Lifetime Achievement Award in Artificial Organs Development https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23018408-asaio-logo-800x800.jpeg https://thebostonexaminer.com/article/911410109-engineer-brothers-launch-automata-studio-an-ai-native-software-and-marketing-agency The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 Engineer Brothers Launch Automata Studio, an AI-Native Software and Marketing Agency https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851315-founders-1448x1086.png https://thebostonexaminer.com/article/911627983-authoronair-launches-ai-podcast-host-that-reads-your-book-before-the-interview The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 AuthorOnAir Launches AI Podcast Host That Reads Your Book Before the Interview https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851818-authoronair-com-hp-13-202605091-2400x1350.png https://thebostonexaminer.com/article/912055087-abg-commercial-realty-facilitates-12-9-million-sale-of-westford-regency-inn-conference-center The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 ABG Commercial Realty Facilitates $12.9 Million Sale of Westford Regency Inn & Conference Center https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24853376-219-littleton-rd-1297x762.jpeg https://thebostonexaminer.com/article/911450497-easton-select-group-expands-north-shore-presence-with-acquisition-of-j-gallant-pool The Boston Examiner en PressRelease 2026-05-12T12:15:00+00:00 Easton Select Group Expands North Shore Presence with Acquisition of J. Gallant Pool https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24027682-easton-select-logo-1147x298.jpeg https://thebostonexaminer.com/article/911086522-bioventrix-names-carl-byrnes-chief-financial-officer The Boston Examiner en PressRelease 2026-05-12T10:30:00+00:00 BioVentrix® Names Carl Byrnes Chief Financial Officer https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850114-carl-byrnes-1254x1254.jpeg https://thebostonexaminer.com/article/912351454-stran-company-reports-31-2-million-in-revenue-and-achieves-ebitda-of-1-0-million-for-the-first-quarter-of-2026 The Boston Examiner en PressRelease 2026-05-12T20:46:30+00:00 Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026 https://ml.globenewswire.com/media/a5974fda-fa3a-4525-a4be-0ffb58879436/small/stran-new-logo-jpg.jpg https://thebostonexaminer.com/article/912351138-crescent-biopharma-announces-grants-of-inducement-awards The Boston Examiner en PressRelease 2026-05-12T20:30:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://thebostonexaminer.com/article/912351195-solid-biosciences-reports-first-quarter-2026-financial-results-and-provides-business-updates The Boston Examiner en PressRelease 2026-05-12T20:08:21+00:00 Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://thebostonexaminer.com/article/912327210-neumora-therapeutics-to-participate-in-2026-rbc-capital-markets-global-healthcare-conference The Boston Examiner en PressRelease 2026-05-12T20:05:00+00:00 Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg https://thebostonexaminer.com/article/912327213-fractyl-health-reports-first-quarter-2026-financial-results-and-business-updates The Boston Examiner en PressRelease 2026-05-12T20:05:00+00:00 Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/3a379315-9c07-4655-883e-7e7f26c67778/small/fractyl-logo-png.png https://thebostonexaminer.com/article/912327333-atea-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update The Boston Examiner en PressRelease 2026-05-12T20:05:00+00:00 Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://thebostonexaminer.com/article/912327452-damora-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights The Boston Examiner en PressRelease 2026-05-12T20:05:00+00:00 Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png https://thebostonexaminer.com/article/912327168-aura-biosciences-to-participate-in-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-12T20:01:00+00:00 Aura Biosciences to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://thebostonexaminer.com/article/912327659-molecular-partners-reports-financial-results-and-highlights-for-q1-2026-with-clinical-studies-initiated-on-mp0712-and-mp0317 The Boston Examiner en PressRelease 2026-05-12T20:00:00+00:00 Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317 https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg https://thebostonexaminer.com/article/912304554-ai-powered-crop-micronutrients-market-attracts-3-15-billion-in-investment-driven-by-precision-agriculture-revolution The Boston Examiner en PressRelease 2026-05-12T17:58:33+00:00 AI-Powered Crop Micronutrients Market Attracts $3.15 Billion in Investment, Driven by Precision Agriculture Revolution https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://thebostonexaminer.com/article/912304489-hubg-alert-hub-group-investigated-for-securities-fraud-investors-should-contact-block-leviton-to-potentially-recover-losses The Boston Examiner en PressRelease 2026-05-12T17:39:39+00:00 HUBG ALERT: Hub Group Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg https://thebostonexaminer.com/article/912262647-ahold-delhaize-usa-appoints-vipin-gopal-to-lead-data-and-ai The Boston Examiner en PressRelease 2026-05-12T14:00:00+00:00 Ahold Delhaize USA Appoints Vipin Gopal to Lead Data and AI https://ml.globenewswire.com/media/cab52a78-54be-4e34-a33f-a1c1da142938/medium/ahold-delhaize-usa-appoints-vipin-gopal-to-lead-data-and-ai.png https://thebostonexaminer.com/article/912262894-earned-signs-washington-nationals-prospect-miguel-sime-jr-as-brand-ambassador The Boston Examiner en PressRelease 2026-05-12T13:35:09+00:00 EARNED Signs Washington Nationals Prospect Miguel Sime Jr. as Brand Ambassador https://ml.globenewswire.com/media/70b36e31-d12f-4151-991e-2425ad8043fd/medium/earned-x-miguel-sime-jr.jpg https://thebostonexaminer.com/article/912244503-agios-submits-snda-to-fda-for-u-s-accelerated-approval-of-mitapivat-in-sickle-cell-disease The Boston Examiner en PressRelease 2026-05-12T13:31:00+00:00 Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://thebostonexaminer.com/article/912244021-beam-therapeutics-to-present-updated-biomarker-data-from-phase-1-2-beacon-trial-further-underscoring-risto-cel-s-ability-to-restore-red-blood-cell The Boston Examiner en PressRelease 2026-05-12T13:30:00+00:00 Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://thebostonexaminer.com/article/912244194-cogent-biosciences-announces-multiple-presentations-at-the-european-hematology-association-eha-2026-congress The Boston Examiner en PressRelease 2026-05-12T13:30:00+00:00 Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://thebostonexaminer.com/article/912244306-disc-medicine-announces-multiple-presentations-across-portfolio-at-the-european-hematology-association-eha-2026-congress The Boston Examiner en PressRelease 2026-05-12T13:30:00+00:00 Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://thebostonexaminer.com/article/912244522-agios-to-present-new-data-at-eha-2026-reinforcing-the-significant-therapeutic-impact-of-mitapivat-across-multiple-rare-hemolytic-anemias The Boston Examiner en PressRelease 2026-05-12T13:30:00+00:00 Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://thebostonexaminer.com/article/912243707-rapid7-launches-cyber-governance-risk-and-compliance-grc-early-access-program-to-unify-security-data-risk-context-and-compliance-workflows The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 Rapid7 Launches Cyber Governance, Risk, and Compliance (GRC) Early Access Program to Unify Security Data, Risk Context, and Compliance Workflows https://ml.globenewswire.com/media/06ff63c6-b10c-4136-b7b8-ee70f03d0bfd/small/rapid7-logo.jpg https://thebostonexaminer.com/article/912243854-ai-adoption-accelerates-in-accounting-yet-fragmented-tools-keep-efficiency-just-out-of-reach-according-to-new-progress-software-report The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 AI Adoption Accelerates in Accounting, Yet Fragmented Tools Keep Efficiency Just Out of Reach, According to New Progress Software Report https://ml.globenewswire.com/media/2a4a917f-af24-458f-b64e-25e5e5cc6c26/small/progress-logo-jpg.jpg https://thebostonexaminer.com/article/912243967-tier-one-partners-named-to-provoke-media-s-2026-best-agencies-lists The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 Tier One Partners Named to PRovoke Media’s 2026 Best Agencies Lists https://ml.globenewswire.com/media/a0b4ce8b-6438-4ffc-8143-50ffb37674ce/small/tier-one-logo-jpg.jpg https://thebostonexaminer.com/article/912243983-mks-inc-declares-quarterly-cash-dividend The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 MKS Inc. Declares Quarterly Cash Dividend https://ml.globenewswire.com/media/a922cdbe-9964-4f52-86d5-ff5e42639bb0/small/mks-color-logo-jpg.jpg https://thebostonexaminer.com/article/912244012-71-of-organizations-suffered-at-least-one-identity-breach-in-the-past-year-sophos-research-finds The Boston Examiner en PressRelease 2026-05-12T13:00:00+00:00 71% of Organizations Suffered At Least One Identity Breach in the Past Year, Sophos Research Finds https://ml.globenewswire.com/media/35db908a-b7b8-4ce0-b920-69875da346ba/small/sophos-1200x628-png.png https://thebostonexaminer.com/article/912244802-fortis-life-sciences-awards-2026-abnano-vhh-discovery-grant-to-deliver-biosciences-for-targeted-drug-delivery-research The Boston Examiner en PressRelease 2026-05-12T12:40:00+00:00 Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://thebostonexaminer.com/article/912244004-akari-therapeutics-secures-key-european-patent-for-its-novel-rna-splicing-modulator-adc-payload-strengthening-global-ip-estate-for-all-major-global The Boston Examiner en PressRelease 2026-05-12T12:33:00+00:00 Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://thebostonexaminer.com/article/912243944-byrna-technologies-sets-upcoming-investor-conference-schedule The Boston Examiner en PressRelease 2026-05-12T12:00:00+00:00 Byrna Technologies Sets Upcoming Investor Conference Schedule https://ml.globenewswire.com/media/b37ace10-a2b7-4002-8d20-1f4aff9c06c8/small/byrna-technologies-logo-jpg.jpg https://thebostonexaminer.com/article/912244299-corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update The Boston Examiner en PressRelease 2026-05-12T12:00:00+00:00 Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://thebostonexaminer.com/article/912244347-rhythm-pharmaceuticals-announces-new-data-presentations-at-the-2026-european-congress-of-endocrinology The Boston Examiner en PressRelease 2026-05-12T12:00:00+00:00 Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://thebostonexaminer.com/article/912244420-cerevance-completes-enrollment-in-pivotal-phase-3-parkinson-s-disease-trial-and-closes-oversubscribed-20-million-series-c-to-extend-runway-into-2027 The Boston Examiner en PressRelease 2026-05-12T12:00:00+00:00 Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027 https://ml.globenewswire.com/media/7b8bba27-38bb-484c-afef-fc5a539ec4e5/small/cerevance-logo-px-jpg.jpg https://thebostonexaminer.com/article/912225796-collegium-completes-acquisition-of-azstarys-from-corium-therapeutics The Boston Examiner en PressRelease 2026-05-12T11:31:46+00:00 Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg https://thebostonexaminer.com/article/912225296-compass-therapeutics-to-participate-in-upcoming-may-investor-events The Boston Examiner en PressRelease 2026-05-12T11:30:00+00:00 Compass Therapeutics to Participate in Upcoming May Investor Events https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://thebostonexaminer.com/article/912225437-zevra-therapeutics-to-present-at-the-h-c-wainwright-bioconnect-investor-conference The Boston Examiner en PressRelease 2026-05-12T11:30:00+00:00 Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://thebostonexaminer.com/article/912225454-harvard-bioscience-announces-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-05-12T11:30:00+00:00 Harvard Bioscience Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6784a4a6-c259-489c-8b5b-05266f41b06f/small/hbio-logo-png.png https://thebostonexaminer.com/article/912225583-xilio-therapeutics-reports-first-quarter-2026-financial-results-and-provides-pipeline-and-business-updates The Boston Examiner en PressRelease 2026-05-12T11:30:00+00:00 Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://thebostonexaminer.com/article/912225294-sionna-therapeutics-reports-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 Sionna Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://thebostonexaminer.com/article/912225344-foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-may The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://thebostonexaminer.com/article/912225346-arbor-biotechnologies-achieves-unprecedented-precise-in-vivo-reverse-transcriptase-editing-in-the-brain-using-a-single-aav-vector-opening-a-new-path The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases https://ml.globenewswire.com/media/68842426-d5ae-4dd2-800a-89d80ad4b3b7/small/arbor-biotech-logo-web-3-1-jpg.jpg https://thebostonexaminer.com/article/912225364-acumen-pharmaceuticals-reports-first-quarter-2026-financial-results-and-business-highlights The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://thebostonexaminer.com/article/912225403-seres-therapeutics-to-participate-in-h-c-wainwright-4th-annual-bioconnect-investor-conference The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://thebostonexaminer.com/article/912225577-c4-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://thebostonexaminer.com/article/912225749-climb-bio-to-present-at-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-12T11:00:00+00:00 Climb Bio to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg